Full Library
Herpes Simplex and Varicella Zoster in Transplant Candidates and Recipients
Resource type
Book Section
Authors/contributors
- Morris, Michele I. (Editor)
- Kotton, Camille Nelson (Editor)
- Wolfe, Camille (Editor)
- Zuckerman, Richard A. (Author)
Title
Herpes Simplex and Varicella Zoster in Transplant Candidates and Recipients
Abstract
Herpes Simplex Virus (HSV) 1 and 2 and Varicella Zoster Virus (VZV) are ubiquitous alpha-herpes viruses that establish lifelong latency in nerve root ganglia. They are characterized by clinical and subclinical reactivation which can lead to significant morbidity in the transplant population. Primary infection after transplant can also be highly morbid, potentially fatal. Despite significant advances in screening, diagnosis, treatment and prevention, there are further gains to be made in managing these infections in transplant recipients. Thankfully, there are novel modalities on the horizon such that these viral infections could become significantly less morbid in the future.
Book Title
Emerging Transplant Infections
Date
2021
Publisher
Springer International Publishing
Place
Cham
Pages
617-654
ISBN
978-3-030-01751-4
Accessed
10/23/21, 9:35 AM
Language
en
Library Catalog
DOI.org (Crossref)
Extra
Citation
Zuckerman, R. A. (2021). Herpes Simplex and Varicella Zoster in Transplant Candidates and Recipients. In M. I. Morris, C. N. Kotton, & C. Wolfe (Eds.), Emerging Transplant Infections (pp. 617–654). Springer International Publishing. https://doi.org/10.1007/978-3-030-01751-4_26-1
TEXTBOOKS
Link to this record